Clinical Study
Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors
Table 4
Uni- and multivariate analyses of late toxicity risk factors.
| Late toxicity | Univariate analysis | Multivariate analysis | Factor | value | Factor | value | HR/CI |
| Dental damages | Initial dental hygiene | 0.0001 | Initial dental hygiene | 0.0001 |
0.47 (0.33–0.68) | Gender | 0.02 | Chemotherapy | 0.03 |
| Trismus | T Stage | 0.01 | — | | | Age | 0.01 | Age | 0.01 | 0.57 (0.36–0.89) | Gender | 0.0001 | Gender | 0.0001 | 2.25 (1.53–3.) |
| Neck fibrosis | N Stage | 0.0001 | N Sage | 0.0001 | 1.34 (1.14–1.59) | Gender | 0.006 | — | Chemotherapy | 0.001 | — |
| Hearing impairment | Gender | 0.0001 | Gender | 0.001 | 1.78 (1.25–2.54) | Total dose | 0.02 | Total dose | 0.02 | 0.64 (0.44–0.94) |
| Neurotoxicity
| Age | 0.04 | — | | | Radiotherapy modality | 0.02 | — | | |
| Endocrine dysfunction | Age | 0.002 | — | | | Gender | 0.04 | — | | |
| Osteoradionecrosis | Initial dental hygiene | 0.04 | — | | | Dental mobility | 0.04 | | | |
|
|
Abbreviations: HR: Hazard Ratio; CI: Confidence Interval.
|